Novel Therapeutic Approaches Targeting Vascular Endothelial Growth Factor and its Receptors in Haematological Malignancies

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|5|8|573-578

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.5, Iss.8, 2005-12, pp. : 573-578

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiangiogenic agents targeting vascular endothelial growth factor and its receptors in clinical development

By Sepp-Lorenzino Laura   Thomas Kenneth A  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 10, 2002-10 ,pp. : 1447-1465

Informa Healthcare

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor and Its Receptor as Drug Targets in Hematological Malignancies

By  

Current Drug Targets, Vol. 8, Iss. 2, 2007-02 ,pp. : 257-268

Bentham Science Publishers

Access to resources Recommend Favorite

Blocking the interaction of vascular endothelial growth factor receptors with their ligands and their effector signaling as a novel therapeutic target for cancer: time for a new look?

By Bruce David   Tan Peng H  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 10, 2011-10 ,pp. : 1413-1434

Informa Healthcare

Access to resources Recommend Favorite

Targeting vascular endothelial growth factor in angina therapy

By Boodhwani Munir   Ramlawi Basel   Laham Roger J   Sellke Frank W  

Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 1, 2006-02 ,pp. : 5-14

Informa Healthcare

Access to resources Recommend Favorite

Targeting the proteasome as a therapeutic strategy against haematological malignancies

By Orlowski Robert Z   Zeger Erik L  

Expert Opinion on Investigational Drugs, Vol. 15, Iss. 2, 2006-02 ,pp. : 117-130

Informa Healthcare

Access to resources Recommend Favorite